Percheron Therapeutics (ASX:PER) warned shareholders about an unauthorized letter and pre-filled proxy form sent by requisitioning shareholder Powerhouse Ventures ahead of its April 24 general meeting, according to a Tuesday filing with the Australian bourse.
The documents, which falsely appeared to be from Percheron, directly reply to an unknown third party not approved to handle proxies, the filing said.
The company urged shareholders to submit forms directly to its registry, Boardroom, to ensure validity.
Shares of the company fell 17% in recent Tuesday trade
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。